The molecular mechanism underlying long-term potentiation (LTP) is critical for understanding learning and memory. CaMKII, a key kinase involved in LTP, is both necessary and sufficient for LTP induction. However, how CaMKII gives rise to LTP is currently unknown. Recent studies suggest that Rho GTPases are necessary for LTP. Rho GTPases are activated by Rho guanine exchange factors (RhoGEFs), but the RhoGEF(s) required for LTP also remain unknown. Here, using a combination of molecular, electrophysiological, and imaging techniques, we show that the RhoGEF Kalirin and its paralog Trio play critical and redundant roles in excitatory synapse structure and function. Furthermore, we show that CaMKII phosphorylation of Kalirin is sufficient to enhance synaptic AMPA receptor expression, and that preventing CaMKII signaling through Kalirin and Trio prevents LTP induction. Thus, our data identify Kalirin and Trio as the elusive targets of CaMKII phosphorylation responsible for AMPA receptor up-regulation during LTP.
proteins cannot be solely responsible for LTP. One possible explanation is that Kalirin supports LTP along with a functionally redundant, as-yet unidentified RhoGEF protein.
Here we used molecular, imaging, and electrophysiological approaches to evaluate the contributions of RhoGEFs to excitatory synapse structure, function, and plasticity in hippocampal CA1 neurons. Our findings demonstrate, for the first time to our knowledge, that the Kalirin paralog Trio plays an important role in postsynaptic function, and that Trio and Kalirin serve critical and functionally redundant roles in supporting excitatory synapse structure and function in CA1 pyramidal cells of the hippocampus. We also report that although inhibiting Kalirin function alone has no effect on LTP, simultaneously inhibiting CaMKII signaling through Kalirin and Trio eliminates LTP induction. Furthermore, phosphorylation of Kalirin-7 by CaMKII is sufficient to enhance synaptic AMPAR-mediated synaptic transmission. Taken together, our data strongly suggest that NMDAR-mediated activation of CaMKII induces functional LTP through phosphorylation of Kalirin and Trio, which then give rise to the synaptic changes underlying synaptic AMPAR up-regulation.
Results
Initially, in an effort to understand how enhancing Kalirin function influences CA1 pyramidal neurons, we increased Kalirin expression in these neurons. We did this using biolistic transfection to overexpress the primary hippocampal isoform of Kalirin, Kalirin-7 (Kal-7), in CA1 pyramidal neurons of organotypic rat hippocampal slice cultures. At 6-7 d after transfection, we analyzed the size of dendritic spines and found that Kal-7 OE resulted in a significant increase in spine size (Fig. S1A) , as previously reported in dissociated cortical neurons (9) .
We then made recordings of AMPAR-and NMDAR-evoked excitatory postsynaptic currents (AMPAR-and NMDAR-eEPSCs, respectively) from fluorescent transfected neurons overexpressing Significance Long-term potentiation (LTP), a form of synaptic plasticity that results in the strengthening of glutamatergic synapses, is believed to be the cellular mechanism underlying learning and memory. LTP is induced by calcium influx through NMDA receptors, which in turn activates CaMKII; however, the substrates that CaMKII phosphorylate that ultimately give rise to LTP have been the subject of debate for more than two decades. Here we show that the RhoGEF proteins Kalirin and Trio are the substrates of CaMKII responsible for LTP induction. Furthermore, we show that glutamatergic synapses require Kalirin and Trio, given that such synapses no longer exist in the absence of these proteins.
Kal-7 and neighboring untransfected control neurons simultaneously during stimulation of Schaffer collaterals. This approach permitted a pairwise, internally controlled comparison of the consequences of the genetic manipulation. Interestingly, we found that Kal-7 OE for 6 d in CA1 pyramidal neurons produced a nearly threefold increase in AMPAR-eEPSC amplitude ( Fig. 1 B and E) . This enhancement was selective for AMPAR-eEPSCs, in that no change in NMDAReEPSC amplitude was observed ( Fig. 1 B and E) .
Next, in an effort to identify an additional RhoGEF protein that may have a function similar to Kalirin, we initially selected Kalirin's paralog Trio. Trio is found in numerous brain regions, is synaptically expressed in hippocampal neurons, and at the amino acid level has a high level of sequence homology to Kalirin (11) . Specifically, we chose Trio's most abundant isoform in the hippocampus, Trio-9 ( Fig. 1A) (12, 13) . When we overexpressed Trio-9, we found that this produced an increase in synaptic AMPAR expression nearly identical to that seen with Kal-7 ( Fig. 1 C and E) . Increases in AMPAR current amplitude produced by Kalirin and Trio were independent of Schaffer collateral stimulation intensity (Fig. S1 B and C) and, like LTP (14) , resulted from increases in quantal content, presumably due to the unsilencing of synapses (Fig. S1D) .
We then examined the effects of overexpressing Tiam1, a RhoGEF that, like Kalirin, is phosphorylated by CaMKII and has been previously implicated in the structure of hippocampal synapses (15, 16) (Fig. 1A) . Tiam1 OE produced no effect on AMPAR-or NMDAR-eEPSC amplitude (Fig. 1 D and E) and was not studied further. Taken together, the foregoing data demonstrate that Kalirin and Trio influence synaptic transmission in a similar manner that is not common to all RhoGEFs.
Given that Kal-7 and Trio-9 behave similarly when overexpressed, we wanted to know whether endogenous Kalirin and Trio proteins play similar roles in synaptic transmission. To test this, we used an miRNA construct targeting the primary hippocampal isoforms of Kalirin (Kal-miR) and an shRNA construct targeting the primary hippocampal isoforms of Trio (Trio-shRNA), and performed Western blot and RT-PCR analyses to confirm RNAi effectiveness (Fig. S2 A-C) . We then knocked down Kalirin expression for 6 d in CA1 pyramidal neurons, and found that this reduced AMPAR-eEPSC amplitude by ∼60% and NMDAReEPSC amplitude by ∼30% (Fig. 2 A and D) . Expression of Kal-miR in CA1 pyramidal neurons from Kalirin KO mice (10) failed to affect glutamatergic transmission, demonstrating that this RNAi lacks off-target effects (Fig. S2D) . We then knocked down Trio expression in WT CA1 pyramidal neurons for 6 d and found a reduction in AMPAR-eEPSC amplitude nearly identical to that produced by knockdown of Kalirin ( Fig. 2 B and D) . NMDAR-eEPSC amplitude, although modestly reduced, was not significantly affected. Taken together, these results demonstrate for the first time, to our knowledge, that these highly homologous RhoGEFs play similar roles in supporting normal hippocampal excitatory synaptic transmission.
Given that Kalirin and Trio are highly homologous proteins, it stands to reason that they may serve overlapping functions in supporting synaptic transmission. Thus, the expression of one may mitigate the effects of losing the other. To address this question, we simultaneously expressed Kal-miR and Trio-shRNA in CA1 pyramidal neurons. Remarkably, we found that knocking down both Kalirin and Trio expression nearly eliminated AMPAR-and NMDAR-eEPSCs, indicating that these two proteins are critical for synaptic function ( Fig. 2 C and D) . This deficit in synaptic transmission was completely rescued by expression of either a KalmiR-resistant form of Kal-7 or a Trio-shRNA-resistant form of Trio-9 (Fig. S2E) . Therefore, we conclude that Kalirin and Trio are functionally redundant proteins that together play a fundamental role in the function of excitatory synapses.
What could account for this loss of synaptic strength? The fact that the AMPAR-and NMDAR-eEPSCs are reduced to roughly the same extent suggests that the loss could be due to a loss of synapses. To address this possibility, we examined dendritic spine density, considering that most excitatory synapses are formed on spines. There was an ∼80% loss of spines (Fig. 2E) , which correlated well with the functional loss. Thus, our results suggest that Kalirin and Trio proteins together support a level of actin polymerization within spines critical for both the structure and function of excitatory synapses.
We then wanted to know how these RhoGEFs enhance AMPAR expression at excitatory synapses. We find that Kal-7 and Trio-9 are functionally redundant proteins with conserved regions being ∼80% identical at the amino acid level. Given that previous studies provide a framework for studying Kal-7, we chose to use Kal-7 as a representative of these two proteins in our experiments examining Kal-7/Trio-9-mediated increases in AMPAR-eEPSC amplitude. Previous work has shown that synaptic activity leads to activation of Rho GTPases through unidentified RhoGEFs (7). To determine whether Kal-7's ability to increase synaptic AMPAR expression is dependent on synaptic activity, we overexpressed Kal-7 in hippocampal slices cultured in medium containing AP5 to block NMDARs and NBQX to block AMPARs. We found that preventing synaptic activity during Kal-7 OE blocked the ability of Kal-7 to increase AMPAR-eEPSC amplitude ( Fig. 3 A and E) .
Previous work has shown that CaMKII phosphorylates Kal-7 on amino acid T95 (9); therefore, we asked whether preventing CaMKII phosphorylation of this site would prevent Kal-7-mediated synaptic enhancement. Indeed, substituting this threonine with an alanine (T95A) prevented Kal-7 from increasing AMPAR-eEPSC amplitude ( Fig. 3 B and E). We found that inhibiting CaMKII activation also blocked Kal-7's ability to increase AMPAR-eEPSC amplitude (Fig. S3 ). In addition, we found that Kal-7 OE for a shorter period of 3 d, rather than 6 d, did not result in a significant increase in AMPAR currents ( Fig. 3 C and E). Thus, exposure of elevated levels of Kal-7 to synaptic activity over time may give rise to a progressive increase in Kal-7 T95 phosphorylation by CaMKII, leading to enhanced synaptic AMPAR transmission. In an effort to test this hypothesis, we overexpressed a mutant of Kal-7 mimicking T95 phosphorylation, Kal-7 (T95E), for 3 d in slices cultured in AP5 and NBQX. Remarkably, Kal-7 (T95E) increased AMPAR-eEPSC amplitude 3 d earlier than WT Kal-7, and did so in the absence of synaptic activity (Fig. 3 D and E) . Taken together, these data demonstrate that phosphorylation of Kal-7 T95 is sufficient for enhancement of AMPAR-mediated synaptic transmission. We also found that Cdc42, a Rho GTPase recently implicated in LTP induction (7, 8) , was also required for the action of Kal-7 to increase AMPAR-eEPSC amplitude (Fig. S4) ; thus, Cdc42 may connect Kalirin activity to downstream pathways associated with LTP.
To explore whether Kalirin and Trio proteins contribute to LTP, we used in utero electroporation of embryonic day (E) 15 mice to express either Kal-miR or Trio-shRNA in hippocampal neurons and examined LTP in electroporated CA1 pyramidal neurons of postnatal day (P)17-P24 mice. We found that knockdown of Kalirin expression alone had little effect on LTP (Fig. 4A ). This finding is consistent with a previous report (10) , as well as with our own data demonstrating LTP in mice lacking all Kalirin isoforms (Fig. S5A) . LTP was also observed in rat CA1 pyramidal cells following a more acute knockdown of Kalirin expression using a Kal-miR-expressing lentivirus ( expression, on the other hand, produced a moderate reduction of LTP (Fig. 4B ). Of note, however, is that neither manipulation prevented LTP induction. Taken together, these data demonstrate that although Kalirin and Trio may be involved in LTP, neither is individually responsible for LTP induction. Given that Kalirin and Trio are functionally redundant proteins in their support of synaptic structure and function, it stands to reason that they would serve functionally redundant roles in their support of LTP. Ideally, this would be investigated by examining LTP following simultaneous knockdown of Kalirin and Trio expression; however, this was not feasible, because synaptic transmission, including the NMDAR-eEPSC, was profoundly impaired (Fig. 2C) . Our goal was then to develop a strategy whereby the ability of Kalirin and Trio to maintain basal synaptic transmission, including NMDAR-eEPSCs, was left intact, but the ability of CaMKII to act on these proteins was disrupted. We found that Kal-7 restored baseline levels of AMPAR-mediated synaptic transmission independent of CaMKII and T95 (Fig. S3 D-F) . Furthermore, Kal-7's ability to increase AMPAR-eEPSC amplitude above baseline levels required CaMKII activation (Fig. S3 A-C) . Therefore, we conclude that a CaMKII/ T95-independent baseline level of Kal-7 activity supports baseline AMPAR-and NMDAR-mediated synaptic transmission, and that CaMKII phosphorylation of T95 is specifically required to boost Kal-7 activity and increase synaptic AMPAR expression above baseline levels. We also found that expression of Kal-7 (T95A) prevented Trio-9 OE from increasing AMPAR-eEPSC amplitude without compromising baseline glutamatergic transmission ( Fig. 5 A and B) . Thus, Kal-7 (T95A) competes with the ability of recombinant Trio to enhance synaptic AMPAR expression. Such competition likely results from the limited number of Kalirin/Trio molecules that are available at a synapse. Therefore, we reasoned that expressing the Kal-miR while at the same time using a strong promoter to drive the expression of recombinant Kal-7 (T95A) should eliminate endogenous Kalirin expression and outcompete the influence of endogenous Trio proteins with a form of Kal-7 that cannot be phosphorylated by CaMKII. This manipulation should thus prevent CaMKII signaling through both proteins without effecting baseline transmission. We first tested the effectiveness of this strategy using a constitutively active form of CaMKII (CA-CaMKII). Short-term OE of CA-CaMKII produced a selective increase in AMPA-eEPSC amplitude (Fig. S6 A and D) , which is generally considered a proxy for LTP (17, 18) . We found that coexpression of Kal-miR and Kal-7 (T95A), but not of WT Kal-7, eliminated the ability of CA-CaMKII to increase AMPAReEPSC amplitude (Fig. S6 B-D) .
Taken together, our data suggest that coexpression of Kal-miR and Kal-7 (T95A) can be used to maintain the CaMKII-independent synapse-supporting role of Kalirin/Trio and, most importantly, NMDAR-EPSCs while disrupting the ability of CaMKII to signal via these two RhoGEFs. Therefore, if CaMKII phosphorylation of Kalirin and Trio are required for LTP induction, then coelectroporation of CA1 pyramidal neurons with Kal-miR and Kal-7 (T95A) should block LTP without compromising baseline transmission. As expected, we found that this manipulation did not affect baseline AMPAR-or NMDAR-eEPSC amplitude (Fig. 5C and Fig. S7 A  and B) . Remarkably, however, coexpression of Kal-miR with Kal-7 (T95A) completely prevented LTP induction (Fig. 5D ). On the other hand, coexpression of Kal-miR with Kal-7 supported LTP induction (Fig. S7C) . Because the Kal-7 T95 residue is conserved in Trio, we mutated this threonine to an alanine in Trio-9 [Trio-9 (T66A)]. Coexpression of Trio-shRNA and Trio-9 (T66A) in CA1 pyramidal neurons also prevented the induction of LTP without affecting baseline glutamatergic transmission (Fig. 5 C and E) .
Considering that inhibiting Kalirin or Trio function alone does not prevent LTP, our data strongly suggest that simultaneously inhibiting the ability of Kalirin and Trio to enhance synaptic AMPAR expression is required to block LTP, and indicate that the role of CaMKII in LTP can be accounted for by an ability to phosphorylate both of these proteins.
Discussion
Here we show that the RhoGEFs Kalirin and Trio together play two essential roles at excitatory synapses in the hippocampus. First, our data demonstrate that Kalirin and Trio proteins serve largely redundant and critical roles in maintaining the structural and functional integrity of excitatory synapses in the hippocampus (Fig. S8 A and B) . The mechanism underlying this role is still poorly understood, but likely involves the ability of Kalirin and Trio proteins to maintain the actin polymerization critical for the structural stability of dendritic spines. Second, Kalirin and Trio appear to serve largely redundant roles in supporting LTP, with these two RhoGEFs likely representing the immediate downstream targets of CaMKII during LTP induction (Fig. S8 A and  C) . These two modes of action of Kalirin and Trio appear to be independent, in that disruption of CaMKII signaling through Kal-7 has no effect on synaptic integrity.
Our data demonstrate that Kalirin and Trio are functionally redundant proteins that together play a fundamental role in the structure and function of excitatory synapses. Previous studies in Kalirin KO mice have found moderately reduced spine density in cortical neurons (19) , but either no change (10, 19) similarity, it is reasonable to infer that Kalirin and Trio serve similar roles in supporting synaptic structure. Interestingly, we found that knockdown of Kalirin or Trio expression individually resulted in a largely AMPAR-specific dysfunction, with NMDAR function mostly preserved, indicating that the total number of synapses in hippocampal CA1 pyramidal neurons is preserved by eliminating Kalirin or Trio alone. However, knockdown of Kalirin and Trio simultaneously resulted in near-complete elimination of synaptic AMPAR-and NMDAR-mediated currents and dendritic spines. Thus, a level of actin polymerization sufficient to support excitatory synapses cannot be maintained in the absence of both Kalirin and Trio. We assert that the variability in spine phenotypes observed following knockout and knockdown of Kalirin expression arises from the degree to which Trio proteins are able to compensate for the loss of Kalirin. Previous studies have suggested that the RhoGEF Kalirin may play a role in sLTP and LTP (9, 21); however, knockdown or knockout of the expression of all Kalirin isoforms in mice does not prevent LTP induction (Fig. 4A and Fig. S5) (10) . Therefore, although Kalirin might still be involved in LTP, it is not solely responsible for its induction. One possible explanation for this is that Kalirin and Trio represent redundant proteins supporting LTP.
To selectively inhibit CaMKII signaling through both Kalirin and Trio, we coexpressed Kal-miR and Kal-miR-resistant Kal-7 (T95A). We performed this manipulation to eliminate endogenous Kalirin expression and out-compete the influence of endogenous Trio proteins with a form of Kal-7 that cannot be phosphorylated by CaMKII. Remarkably, this manipulation completely eliminated LTP induction without affecting baseline glutamatergic neurotransmission. Although we believe Kal-7 (T95A)-mediated inhibition of Trio function arises from a dilution of endogenous Trio proteins, we cannot exclude the possibility that Kal-7 (T95A) acts as a dominant negative against Trio function. For example, it may be possible that Kal-7 (T95A) gains preferential access to Kalirin/ Trio binding sites at synapses. We also discovered that mutating the same threonine to an alanine in Trio-9 blocked LTP when expressed in CA1 pyramidal neurons. The foregoing findings demonstrate that the importance of this threonine residue is conserved between Kalirin and Trio. Furthermore, Kal-7-mediated enhancement of synaptic AMPAR expression requires Cdc42, a Rho GTPase recently found to be critical in LTP and sLTP (7, 8) . Although Kalirin and Trio are not thought to activate Cdc42 directly, they might activate Cdc42 indirectly through their ability to activate RhoG (22) . We have also shown that mimicking CaMKII phosphorylation of Kal-7 T95 is sufficient to selectively and robustly enhance synaptic AMPAR expression in the absence of synaptic activity. This finding suggests that the phosphorylation of Kalirin and Trio is instructive in LTP induction rather than permissive. Although one published study did not identify Kal-7 T95 phosphorylation following an in vitro CaMKII phosphorylation assay (23) , another earlier study did identify T95 as a CaMKII phosphorylation site (9) . Our data strongly agree with the earlier study, given our finding that T95 is required for Kal-7-and CACaMKII-mediated enhancement of synaptic AMPAR transmission. We also found that phosphonull and phosphomimetic mutations of T95 bidirectionally control Kal-7 function in neurons. Taken together, our data strongly suggest that CaMKII gives rise to functional LTP through the phosphorylation of Kalirin and Trio, which in turn facilitates actin polymerization and synapse enlargement via activation of Rho GTPases, like Cdc42 (Fig. S8C) .
Previous studies have argued that LTP arises from direct phosphorylation of AMPAR subunits by CaMKII (24) (25) (26) . Conversely, recent work from our laboratory demonstrates that LTP can still be induced when AMPARs are replaced with kainate receptors that share little sequence homology with AMPARs (27) . This finding strongly suggests that AMPARs are not required for LTP induction and is more in line with the synaptic structure-based RhoGEF-mediated mechanism of LTP induction presented in the present study. Given the importance of Kalirin and Trio in CaMKII-dependent LTP, it will be interesting to determine whether these proteins are involved in other forms of synaptic plasticity as well.
Materials and Methods
Electrophysiology. All experiments were performed in accordance with established protocols approved by the University of California, San Francisco's Institutional Animal Care and Use Committee. Whole-cell recordings were performed as described previously (28) . Slice cultures were prepared from P6-P9 rat or mouse pups as described previously (29) and recorded on day in vitro (DIV) 7-8. Acute slices for LTP experiments were prepared from P17-P23 mice. All slices were maintained during recording in artificial cerebrospinal fluid (aCSF) containing 119 mM NaCl, 2.5 mM KCl, 1 mM NaH 2 PO 4 , 26.2 mM NaHCO 3 and 11 mM glucose. For acute slices, 2.5 mM CaCl 2 and 1.3 mM MgSO 4 were added to the aCSF, and 4 mM CaCl 2 and 4 MgSO 4 were added for organotypic slice cultures. The internal whole-cell recording solution contained 135 mM CsMeSO 4 , 8 mM NaCl, 10 mM Hepes, 0.3 mM EGTA, 5 mM QX-314, 4 mM Mg-ATP, and 0.3 mM Na-GTP. Osmolarity was adjusted to 290-295 mOsm, and pH-buffered at 7.3-7.4. Synaptic responses were evoked by stimulating with a monopolar glass electrode filled with aCSF in the stratum radiatum of CA1. Biolistic transfections and E15.5 electroporations were carried out as described previously (30, 31) .
Spine Imaging. Control and experimental CA1 pyramidal neurons in organotypic hippocampal slice cultures were biolistically transfected with FUGW-GFP or FHUGW-GFP/mCherry constructs at ∼18-20 h after plating. At 7-8 d after transfection, confocal imaging was performed on CA1 pyramidal neurons brightly labeled with GFP in live tissue in Hepes-buffered aCSF containing 150 mM NaCl, 2.5 mM KCl, 10 mM Hepes, 10 mM glucose, 1 mM MgCl 2 , and 2 mM CaCl 2 using a Nikon Spectral C1si confocal microscope with a NIR Apo 60× W objective. Z-stacks were made of 30-μm sections of secondary apical dendrites using EZ-C1 software (Nikon). Imaging was performed on two or three dendrites per neuron, and the spine density was averaged. Statistical significance was determined using the Mann-Whitney U test.
